The purpose of this study was to determine the effect of the MLS laser on the injured tibial and peroneal nerves in diabetic sensory neuropathy. A controlled prospective study was performed on ten patients with documented type 2 diabetes and peripheral sensory neuropathy.
In this pilot study, MLS therapy appears to be uniquely capable of healing the injured nerve in DPN and shows great promise in the battle against the devastating sequelae of this disease.
A goldfish receives MLS Laser Therapy to treat bacterial granuloma, showing significant improvement after 5 days of treatment.
Cutting Edge Laser Technologies is proud to announce the launch of the new Robotic M7 MLS Therapy Laser!
As a result of decreasing insurance reimbursements and other operational challenges, Dr. Joel Foster began searching for a solution that would enhance patient outcomes while streamlining practice operations and generating cash-based revenue.